Thursday, October 30, 2025
1:00 p.m. – 2:00 p.m. ET
Please note this Clinical Conversation program is 1:00 p.m. Eastern, 12:00 p.m. Central, 11:00 a.m. Mountain and 10:00 a.m. Pacific.
PRESENTING FACULTY
 |
Diana R. Kerwin, MD Adjunct Assistant Professor, Department of Neurology University of Texas Southwestern Medical Center Founder and President of Kerwin Medical Center Dallas, Texas |
 |
Neil Skolnik, MD Professor of Family and Community Medicine Sidney Kimmel Medical College Thomas Jefferson University Associate Director Family Medicine Residency Program Abington Jefferson Health Jenkintown, Philadelphia |
PROGRAM OVERVIEW
The PREPARE Clinical Conversations Program is an interactive, case-based educational initiative designed to equip clinicians with the skills to identify and address early cognitive decline in routine practice. Led by experts in primary care and neurology, this program emphasizes the use of validated screening tools, clinical signs and symptoms, and emerging biomarkers to differentiate normal aging from early cognitive impairment. Clinicians will gain expertise in incorporating updated guidelines, conducting meaningful discussions with patients and caregivers, and implementing practical approaches for testing, referrals, and coordinated care management.
TARGET AUDIENCE
This activity is tailored to address the educational needs of healthcare providers, excluding those located in the United Kingdom, who are involved in managing patients with cognitive health concerns. The primary audience includes primary care clinicians and general practitioners (MDs/DOs/NPs/PAs), general neurologists, and geriatricians, with a secondary audience of psychiatrists and OB-GYNs.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Appraise cognitive health screening best practices to differentiate normal aging from early cognitive decline using validated tests, while offering appropriate management strategies and specialist referral
- Justify the use of clinical signs and symptoms, as well as biomarkers, to detect neuropathological changes in cognitive health conditions
- Model the integration of new data and guideline recommendations for cognitive health assessments into clinical practice
- Initiate conversations about cognitive health and cognitive preservation through patient and caregiver discussions and interdisciplinary communication across the cognitive health team
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in this virtually live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this virtually live activity for a maximum of 1.5 ANCC contact hours.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact: Med Learning Group at [email protected].
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at https://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
